Flash e-reader

 Go to e-reader chapter








Table 10.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2005 to 2009

Recipients with Intestine Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 211 100.0% 576 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 2 0.9% 4 0.7%
OKT3 3 1.4% 24 4.2%
Thymoglobulin 93 44.1% 106 18.4%
Zenapax 6 2.8% 69 12.0%
Simulect     14 2.4%
Campath 73 34.6% 63 10.9%
Rituximab 74 35.1% 9 1.6%
No Induction Drug Reported 38 18.0% 326 56.6%


Source: OPTN/SRTR Data as of October 1, 2010.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.